Therefore, our current study proposes new insights into a novel mechanism of ovarian cancer metastasis and chemotherapy resistance, and provides a theoretical basis of possible clinical treatment through PINK1 inhibition. This evidence concerns the gene PINK1 and ovarian cancer.